
|Articles|May 1, 2016
- Pharmaceutical Executive-05-01-2016
- Volume 36
- Issue 5
Pharmaceutical Executive, May 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive May 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 10 years ago
Steering the Change: GSK's Jack Baileyalmost 10 years ago
Pharma’s Big Push for Valuealmost 10 years ago
Pharm Exec at the Vantage Pointalmost 10 years ago
Pharma Under Pressure to Curb Opioid Abusealmost 10 years ago
Country Report: Francealmost 10 years ago
Pharma Under Fire for Driving "Opioid Abuse Epidemic"Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Releases Open Letter Warning of Potential Safety Risks for Compounded Tirzepatide Plus Vitamin B12
2
Pharmaceutical Executive Daily: Senate Democrats Seeking Information on MFN Pharma Deals
3
Navigating Complexity in Emerging Biotech: Innovations, Integrations, and Initial Hurdles
4




